Jorge Diaz
General Practice · Brandon, FLNPI 1699157180
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (46.5%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. Abbott accounts for 68.0% of it on its own, with 24 other manufacturers making up the rest. 2025 is the largest year on record at $6,170, more than ten times the $477 reported in 2019. Among general practice clinicians in FL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 189 payments — averaging $66.06 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$8K
- AstraZeneca$1K
- GSK$915
- AbbVie$353
- Amgen$304
- Lilly USA, LLC$184
- plus $1K from 19 others
What the payments were for
- Consulting fees$5,81047%
- Travel & lodging$2,42619%
- Food & beverage$4,23634%
- Education$140%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 8 | $8,495 |
| AstraZeneca | 52 | $1,232 |
| GSK | 26 | $915 |
| AbbVie(2 entities) | 20 | $353 |
| Amgen | 19 | $304 |
| Lilly USA, LLC | 12 | $184 |
| Bayer | 9 | $169 |
| Boehringer Ingelheim | 7 | $156 |
| Novartis | 6 | $105 |
| Novo Nordisk | 5 | $79 |
| Pfizer | 5 | $75 |
| Scilex Pharmaceuticals Inc. | 1 | $65 |
| Evoke Pharma, Inc. | 3 | $42 |
| Eisai Inc. | 2 | $41 |
| Hologic Sales And Service, LLC | 2 | $41 |
| Astellas Pharma US Inc | 2 | $40 |
| Merck | 2 | $37 |
| Mylan Specialty L.p. | 1 | $33 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $24 |
| Emergent Biosolutions Inc. | 1 | $20 |
| Phadia US Inc. | 1 | $18 |
| Boston Scientific | 1 | $17 |
| Otsuka America Pharmaceutical, Inc. | 1 | $14 |
| Lundbeck LLC | 1 | $14 |
| Sanofi-aventis U.S. LLC | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- AMPLATZER AMULET$6,130
- Accent Pacemaker$2,310
- TRELEGY ELLIPTA$245
- BREZTRI$240
- BREZTRI AEROSPHERE$125
- ANORO ELLIPTA$125
- AREXVY$108
How this compares
$12,486 in reported general payments places this provider in the 95th percentile of 6,901 general practice providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| FarxigaDapagliflozin Propanediol | 158 | $160,015 |
| TrulicityDulaglutide | 109 | $137,169 |
| EliquisApixaban | 95 | $94,356 |
| JardianceEmpagliflozin | 56 | $70,182 |
| LinzessLinaclotide | 58 | $39,283 |
| EntrestoSacubitril/Valsartan | 26 | $36,091 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 50 | $34,777 |
| OzempicSemaglutide | 30 | $31,928 |
| CreonLipase/Protease/Amylase | 16 | $31,088 |
| XareltoRivaroxaban | 43 | $27,310 |
| MounjaroTirzepatide | 21 | $22,047 |
| TradjentaLinagliptin | 17 | $16,775 |
| Tresiba Flextouch U-100Insulin Degludec | 23 | $11,451 |
| Comfort Ez Pen NeedlePen Needle, Diabetic | 115 | $10,335 |
| Breo ElliptaFluticasone/Vilanterol | 20 | $8,649 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AstraZenecaFarxiga, Breztri Aerosphere | $1,232 | $168,049171 claims |
| Lilly USA, LLCTrulicity, Mounjaro | $184 | $159,216130 claims |
| PfizerEliquis | $75 | $94,35695 claims |
| Boehringer IngelheimJardiance, Tradjenta | $156 | $86,95873 claims |
| AbbVieLinzess, Creon | $353 | $70,37174 claims |
| GSKTrelegy Ellipta, Breo Ellipta | $915 | $43,42670 claims |
| NovartisEntresto | $105 | $36,09126 claims |
| Novo NordiskOzempic | $79 | $31,92830 claims |
| Sanofi-aventis U.S. LLCLantus | $13 | $2,50722 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 6,901 general practice providers in Florida.
Other general practice in Brandon
- Fadi RaffoulBrandon$18K
- Ling LiBrandon$17K
- Robert VogelPalm Beach Gardens$1M
- Bruce OuelletteWest Palm Beach$724K
- Caley CasteleinMiami Beach$586K
- Sarah JockinTampa$308K
- Mario RomeroSarasota$275K
- Robert RitterJupiter$233K
- Robert AltharPensacola$231K
- Florencia ZiemkeWest Palm Beach$208K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.